Neurology Market

Neurology Market Share & Analysis – Industry Overview

Base Year: 2024 Historical Data: 2021-23
  • Report ID: TBI-14759
  • Published Date: Jun, 2025
  • Pages: 237
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

Segment Analysis

Regional segmentation analysis

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the most significant global neurology market, with a 42% market revenue share in 2024.

One of the most affected regions worldwide concerning neurological conditions exists in the United States where it encounters elevated occurrences of Alzheimer’s disease alongside Parkinson’s disease and epilepsy and these numbers increase given the aging demographic. The expanding base of neurological patients requires a substantial amount of specialized neurology care and diagnostic services and treatment solutions. North American healthcare facilities operate through advanced medical equipment such as MRI scan and PET scan machines and advanced electrophysiological monitoring tools in their medical centres and hospitals. The medical facilities within North America deliver complete neurological care to their patients by providing advanced services from diagnosis through medical treatment to rehabilitation programs to maintain their regional leadership role. The neurological drug development market is advanced by leading pharmaceutical and biotech companies along with their continuous discoveries, innovations and scientific breakthroughs. The region benefits from extensive research independently conducted by governmental institutions and other private entities as well as universities.

North America Region Neurology Market Share in 2024 - 42%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

  • In order to help countries meet the 2031 targets of the Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders (IGAP), WHO released a new implementation toolkit that outlines specific actions and resources for improving services for individuals with neurological disorders. Globally, neurological disorders are the primary cause of illness and disability. In 2022, the Seventy-fifth World Health Assembly unanimously adopted the neurology action plan, which lays out a comprehensive plan to improve services by promoting research and innovation, lowering discrimination, increasing awareness, and fortifying policies, systems, and services.

Type of neurological disorder Segment Analysis

The type of neurological disorder segment is divided into neurodegenerative diseases, cerebrovascular disorders, epileptic disorders, demyelinating diseases, headache disorders, neuromuscular disorders and others. The neurodegenerative diseases segment dominated the market, with a market share of around 38% in 2024. Alzheimer’s disease, the most common form of dementia, and Parkinson’s disease, a progressive movement disorder, represent major public health concerns, with millions of people worldwide affected. An ample market demand exists because consistent medical intervention is needed for managing symptoms and slowing disease progression. Alzheimer's disease treatment requires disease-modifying therapies that medical professionals heavily seek while Parkinson's disease patients mostly require treatments for symptom management including tremor control and motor dysfunction improvement. Neurodegenerative diseases impose substantial financial strain on healthcare systems because they require extensive patient care so pharmaceutical companies along with healthcare providers maintain this segment as their main focus. Future research directions about disease mechanisms and medication development will sustain the prevalence of neurodegenerative diseases across the neurology market. These conditions will drive market expansion because they exist in high numbers and require expensive care for extended periods.

  • Imagine a society in which early detection is more common, treatment choices are backed by data-driven insights, and neurological diagnoses are established with increased accuracy.  This is the goal of the Mayo Clinic Neurology Artificial Intelligence Program (NAIP), which is spearheading new research in which AI is used as a potent instrument to complement and enhance medical practitioners' knowledge. The NAIP team is evaluating StateViewer, a platform developed by Mayo that uses artificial intelligence to identify similar brain disease cases in Mayo's dispersed data network based on a patient's PET scan. Researchers believe that by improving diagnostic precision, StateViewer will assist care teams in diagnosing dementia, including frontotemporal dementia, Lewy body dementia, and Alzheimer's disease, and assist in directing patient treatment choices.

Treatment type Segment Analysis

The treatment type segment is divided into pharmaceuticals, surgical treatments, diagnostics, therapies and others. The pharmaceuticals segment dominated the market, with a market share of around 37% in 2024. Medical drugs serve essential purposes in neurology treatment by managing symptoms alongside slowing disease advancement and enhancing patient health conditions. There exist disease-modifying therapies (DMTs) that serve as primary treatment options for Alzheimer’s and Parkinson’s disease because they work to stop or delay the progression of these serious conditions. Medications known as antiepileptic drugs function as the core treatment against seizures in epilepsy while specific drugs including triptans and preventive therapies help manage the widespread condition of migraines. The development of molecular biology along with neurogenetics and biopharmaceuticals has led to new therapeutic drugs that match individual genetic characteristics thus producing enhanced efficiency with reduced adverse effects. Pharmaceutical companies dedicate abundant financial resources to neurology R&D because neurological diseases are increasingly prevalent while healthcare professionals seek imperative new treatment methods. Pharmaceuticals play a critical role in prolonged neurology care because most neurological conditions persist for extended periods thus requiring long-term treatment options for both disease modification and symptom control. Neurology market expansion and innovation will continue under advanced pharmaceutical research and drug delivery system developments.

  • The Child Neurology Society (CNS) and Baylor Genetics, a clinical diagnostic laboratory leading the way in genetic testing, announced their partnership as an official 2025–2026 genetic testing partner. With a high diagnostic yield of up to 40–60% and written findings available as soon as five days after patient sample receipt, Baylor Genetics' flagship rapid WGS and WES assays are among the most accurate and quick precision diagnostic techniques on the market.

End user Segment Analysis

The end user segment is divided into hospitals, neurology clinics, ambulatory surgical centers (ASCs), research institutes and others. The hospitals segment dominated the market, with a market share of around 42% in 2024. A hospital offers its patients access to a comprehensive array of diagnosis and treatment solutions at one place. Hospitals offer a complete healthcare atmosphere that allows neurologists neurosurgeons and nurses together with rehabilitation specialists to jointly manage patient care. A team-based care model provides patients with all necessary medical services beginning with diagnosis and extending to treatment as well as rehabilitation and ongoing healthcare follow-ups. Healthcare improvements have solidified hospitals as the primary centres for specialized neurological care thus establishing them as essential institutions for managing these extensive medical issues. The global neurology market largely depends on hospitals because of specialized treatment needs and advanced technology which will sustain their dominant position in serving both acute and chronic neurological needs.

  • In order to transform clinical trials and outcomes measurement for diseases of the central nervous system (CNS), including neurodegenerative, psychiatric, motor, and rare neurodevelopmental disorders, Medidata, a Dassault Systèmes brand and the top supplier of clinical trial solutions to the life sciences sector, announced a collaboration with Cogstate, a leader in neuroscience solutions. By working together, the businesses will provide a better experience, backed by Medidata eCOA (electronic clinical outcome assessment), which gives clients more authority by enabling quicker trial initiation and better rater experiences. This offers a full set of data quality assurance tools for central nervous system (CNS) assessments, as well as a simplified rater trip via a single mobile device app.

Request Table of Content

+1

This study forecasts revenue at global, regional, and country levels from 2021 to 2034. The Brainy Insights has segmented the global neurology market based on below mentioned segments:

Global Neurology Market by Type of Neurological Disorder:

  • Neurodegenerative Diseases
  • Cerebrovascular Disorders
  • Epileptic Disorders
  • Demyelinating Diseases
  • Headache Disorders
  • Neuromuscular Disorders
  • Others

Global Neurology Market by Treatment Type:

  • Pharmaceuticals
  • Surgical Treatments
  • Diagnostics
  • Therapies
  • Others

Global Neurology Market by End User:

  • Hospitals
  • Neurology Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Research Institutes
  • Others

Global Neurology Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date